Colgate Palmolive (India) Limited has informed the Exchange about Investor Presentation
COLPAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colgate Palmolive (India) submitted its investor presentation ahead of the May 22, 2025 analyst call covering Q4 FY25 and FY25 results. For FY25, net sales grew 6.3% to ₹5,999 Crore with net profit up 8.5% at ₹1,437 Crore, gross margin of 69.7%, and advertising spend of ₹822 Crore (13.7% of sales). Q4 FY25 was weaker, with topline declining 1.9% to ₹1,452 Crore and NPAT falling 6.5% to ₹355 Crore, though gross margin expanded 130 bps to 70.4%. The company highlighted mid-single digit toothpaste volume growth, strong brand health metrics, and new product launches across freshness, whitening, and personal care. Management noted that demand recovery is expected to be gradual, likely towards the second half of FY26, while continuing to invest in brand building and innovation.
Mixed picture for shareholders: full-year FY25 delivered steady growth and margin strength, but Q4 showed a dip in revenue and profits with management flagging a gradual demand recovery, which may temper near-term expectations. Strong brand investments and innovation pipeline remain positive medium-term supports.